chr7-48171493-G-A

Variant summary

Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP4_StrongBP6

The NM_152701.5(ABCA13):​c.10G>A​(p.Ala4Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000309 in 1,536,154 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00033 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00031 ( 1 hom. )

Consequence

ABCA13
NM_152701.5 missense

Scores

2
15

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:1

Conservation

PhyloP100: -0.422

Publications

0 publications found
Variant links:
Genes affected
ABCA13 (HGNC:14638): (ATP binding cassette subfamily A member 13) In human, the ATP-binding cassette (ABC) family of transmembrane transporters has at least 48 genes and 7 gene subfamilies. This gene is a member of ABC gene subfamily A (ABCA). Genes within the ABCA family typically encode several thousand amino acids. Like other ABC transmembrane transporter proteins, this protein has 12 or more transmembrane alpha-helix domains that likely arrange to form a single central chamber with multiple substrate binding sites. It is also predicted to have two large extracellular domains and two nucleotide binding domains as is typical for ABCA proteins. Alternative splice variants have been described but their biological validity has not been demonstrated.[provided by RefSeq, Mar 2009]
ABCA13 Gene-Disease associations (from GenCC):
  • schizophrenia
    Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -5 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.019642651).
BP6
Variant 7-48171493-G-A is Benign according to our data. Variant chr7-48171493-G-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 2458275.We mark this variant Likely_benign, oryginal submissions are: {Uncertain_significance=1, Likely_benign=1}.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ABCA13NM_152701.5 linkc.10G>A p.Ala4Thr missense_variant Exon 1 of 62 ENST00000435803.6 NP_689914.3 Q86UQ4A0A0A0MT16

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ABCA13ENST00000435803.6 linkc.10G>A p.Ala4Thr missense_variant Exon 1 of 62 1 NM_152701.5 ENSP00000411096.1 A0A0A0MT16
ABCA13ENST00000417403.5 linkn.10G>A non_coding_transcript_exon_variant Exon 1 of 18 2 ENSP00000409268.1 Q86UQ4-2

Frequencies

GnomAD3 genomes
AF:
0.000342
AC:
52
AN:
152216
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000724
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000131
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.0000941
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000676
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000198
AC:
28
AN:
141750
AF XY:
0.000158
show subpopulations
Gnomad AFR exome
AF:
0.000264
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000447
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000306
AC:
424
AN:
1383820
Hom.:
1
Cov.:
30
AF XY:
0.000290
AC XY:
198
AN XY:
682844
show subpopulations
African (AFR)
AF:
0.0000950
AC:
3
AN:
31566
American (AMR)
AF:
0.00
AC:
0
AN:
35700
Ashkenazi Jewish (ASJ)
AF:
0.0000397
AC:
1
AN:
25182
East Asian (EAS)
AF:
0.00
AC:
0
AN:
35734
South Asian (SAS)
AF:
0.00
AC:
0
AN:
79180
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
34994
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4802
European-Non Finnish (NFE)
AF:
0.000380
AC:
410
AN:
1078864
Other (OTH)
AF:
0.000173
AC:
10
AN:
57798
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.465
Heterozygous variant carriers
0
20
40
60
80
100
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000335
AC:
51
AN:
152334
Hom.:
0
Cov.:
32
AF XY:
0.000349
AC XY:
26
AN XY:
74486
show subpopulations
African (AFR)
AF:
0.0000722
AC:
3
AN:
41570
American (AMR)
AF:
0.000131
AC:
2
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4830
European-Finnish (FIN)
AF:
0.0000941
AC:
1
AN:
10626
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000661
AC:
45
AN:
68028
Other (OTH)
AF:
0.00
AC:
0
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.515
Heterozygous variant carriers
0
4
7
11
14
18
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000427
Hom.:
0
Bravo
AF:
0.000302
ESP6500AA
AF:
0.000723
AC:
1
ESP6500EA
AF:
0.000314
AC:
1
ExAC
AF:
0.0000481
AC:
1
Asia WGS
AF:
0.000289
AC:
1
AN:
3478

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not specified Uncertain:1
Feb 07, 2025
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.10G>A (p.A4T) alteration is located in exon 1 (coding exon 1) of the ABCA13 gene. This alteration results from a G to A substitution at nucleotide position 10, causing the alanine (A) at amino acid position 4 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

not provided Benign:1
Dec 01, 2022
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

ABCA13: BP4 -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Benign
-0.36
T
BayesDel_noAF
Benign
-0.42
CADD
Benign
1.5
DANN
Benign
0.86
Eigen
Benign
-1.4
Eigen_PC
Benign
-1.4
FATHMM_MKL
Benign
0.018
N
LIST_S2
Benign
0.43
T
M_CAP
Benign
0.0084
T
MetaRNN
Benign
0.020
T
MetaSVM
Benign
-0.75
T
PhyloP100
-0.42
PrimateAI
Benign
0.41
T
PROVEAN
Benign
-1.0
N
REVEL
Benign
0.11
Sift
Uncertain
0.0010
D
Sift4G
Uncertain
0.032
D
Vest4
0.15
MVP
0.20
MPC
0.035
ClinPred
0.0082
T
GERP RS
-2.6
PromoterAI
0.00080
Neutral
gMVP
0.12
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs144916268; hg19: chr7-48211090; COSMIC: COSV106115024; API